No statistically significant associations between CAG repeat polymorphism in the AR gene and improvement of disease activity parameters was found, suggesting no correlation between CAG repeat polymorphism in the AR gene and response to treatment with LEF in women with RA [111]. This evidence concerns the gene AR and rheumatoid arthritis.